General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.23.2
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
CleanTech Acquisition Corp
Common Stock
CleanTech Acquisition Corp
Additional Paid-in Capital
CleanTech Acquisition Corp
Accumulated Deficit
CleanTech Acquisition Corp
Series A
Preferred Stock
Series B
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 17, 2020            
Balance (in Shares) at Jun. 17, 2020                  
Sale of 4,312,500 Founder Shares $ 431 24,569   25,000            
Sale of 4,312,500 Founder Shares (in Shares) 4,312,500                  
Net income (loss) (1,000) (1,000)            
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 $ 23,276,615 $ (24,716,902) $ (1,428,721)
Balance (in Shares) at Dec. 31, 2020 4,312,500       334,800 725,426 9,637,962      
Net income (loss) (1,519,682) (1,519,682)
Stock-based compensation         107,794 107,794
Balance at Mar. 31, 2021 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,384,409 (26,236,584) (2,840,609)
Balance (in Shares) at Mar. 31, 2021 4,312,500       334,800 725,426 9,637,962      
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,276,615 (24,716,902) (1,428,721)
Balance (in Shares) at Dec. 31, 2020 4,312,500       334,800 725,426 9,637,962      
Net income (loss)                  
Balance at Jun. 30, 2021 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,484,979 (27,311,495) (3,814,950)
Balance (in Shares) at Jun. 30, 2021 4,312,500       334,800 725,426 9,637,962      
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,276,615 (24,716,902) (1,428,721)
Balance (in Shares) at Dec. 31, 2020 4,312,500       334,800 725,426 9,637,962      
Net proceeds from Initial Public Offering allocated to Rights 3,845,970 3,845,970            
Excess of cash received over fair value of private placement warrants 4,161,500 4,161,500            
Change in fair value of over-allotment option liability 225,000 225,000            
Accretion of Common Stock to possible redemption amount (8,032,039) (7,337,675) (15,369,714)            
Net income (loss) (595,442) (595,442)           $ (15,127,629)
Exercise of stock options (in Shares)                   31,255
Balance at Dec. 31, 2021 $ 431 (7,709,117) (7,708,686) $ 3,348 $ 7,254 $ 967 33,221,505 (39,844,531) $ (6,611,457)
Balance (in Shares) at Dec. 31, 2021 4,312,500       334,800 725,426 9,669,217      
Balance at Mar. 31, 2021 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,384,409 (26,236,584) (2,840,609)
Balance (in Shares) at Mar. 31, 2021 4,312,500       334,800 725,426 9,637,962      
Net income (loss) (1,074,911) (1,074,911)
Stock-based compensation         100,570 100,570
Balance at Jun. 30, 2021 $ 431 24,569 (1,000) 24,000 $ 3,348 $ 7,254 $ 964 23,484,979 (27,311,495) (3,814,950)
Balance (in Shares) at Jun. 30, 2021 4,312,500       334,800 725,426 9,637,962      
Net income (loss)         (1,298,122) (1,298,122)
Stock-based compensation         117,571 117,571
Balance at Sep. 30, 2021         $ 3,348 $ 7,254 $ 964 23,602,550 (28,609,617) (4,995,501)
Balance (in Shares) at Sep. 30, 2021         334,800 725,426 9,637,962      
Net income (loss)         (11,234,914) (11,234,914)
Stock-based compensation         99,645 99,645
Loss on extinguishment of debt         9,484,113 9,484,113
Exercise of stock options         $ 3 35,197 35,200
Exercise of stock options (in Shares)             31,255      
Balance at Dec. 31, 2021 $ 431 (7,709,117) (7,708,686) $ 3,348 $ 7,254 $ 967 33,221,505 (39,844,531) (6,611,457)
Balance (in Shares) at Dec. 31, 2021 4,312,500       334,800 725,426 9,669,217      
Net income (loss) 1,951,670 1,951,670 (3,504,002) (3,504,002)
Stock-based compensation         200,157 200,157
Balance at Mar. 31, 2022 $ 431 (5,757,447) (5,757,016) $ 3,348 $ 7,254 $ 967 33,421,662 (43,348,533) (9,915,302)
Balance (in Shares) at Mar. 31, 2022 4,312,500       334,800 725,426 9,669,217      
Balance at Dec. 31, 2021 $ 431 (7,709,117) (7,708,686) $ 3,348 $ 7,254 $ 967 33,221,505 (39,844,531) (6,611,457)
Balance (in Shares) at Dec. 31, 2021 4,312,500       334,800 725,426 9,669,217      
Net income (loss)       1,155,839            
Balance at Jun. 30, 2022 $ 431 (6,699,162) (6,698,731) $ 3,348 $ 7,254 $ 967 33,610,319 (46,705,489) (13,083,601)
Balance (in Shares) at Jun. 30, 2022 4,312,500       334,800 725,426 9,669,217      
Balance at Dec. 31, 2021 $ 431 (7,709,117) (7,708,686) $ 3,348 $ 7,254 $ 967 33,221,505 (39,844,531) (6,611,457)
Balance (in Shares) at Dec. 31, 2021 4,312,500       334,800 725,426 9,669,217      
Net income (loss)                   (28,260,571)
Balance at Dec. 31, 2022         $ 4,725 68,128,196 (68,105,102) 27,819
Balance (in Shares) at Dec. 31, 2022             47,250,771      
Balance at Mar. 31, 2022 $ 431 (5,757,447) (5,757,016) $ 3,348 $ 7,254 $ 967 33,421,662 (43,348,533) (9,915,302)
Balance (in Shares) at Mar. 31, 2022 4,312,500       334,800 725,426 9,669,217      
Net income (loss) (795,831) (795,831) (3,356,956) (3,356,956)
Remeasurement of common stock subject to redemption amount (145,884) (145,884)            
Stock-based compensation         188,657 188,657
Balance at Jun. 30, 2022 $ 431 $ (6,699,162) $ (6,698,731) $ 3,348 $ 7,254 $ 967 33,610,319 (46,705,489) (13,083,601)
Balance (in Shares) at Jun. 30, 2022 4,312,500       334,800 725,426 9,669,217      
Net income (loss)         (13,176,497) (13,176,497)
Stock-based compensation         235,593 235,593
Cancellation and exchange of convertible note in connection with reverse capitalization         $ 530 14,548,384 14,548,914
Cancellation and exchange of convertible note in connection with reverse capitalization (in Shares)             5,299,546      
Conversion of Series A preferred stock in connection with reverse recapitalization         $ (3,348) $ 476 2,872
Conversion of Series A preferred stock in connection with reverse recapitalization (in Shares)         (334,800) 4,756,470      
Conversion of Series B preferred stock in connection with reverse recapitalization         $ (7,254) $ 1,030 6,224
Conversion of Series B preferred stock in connection with reverse recapitalization (in Shares)         (725,426) 10,306,055      
Reverse recapitalization with Cleantech Acquisition Corp, net         $ 662 (669,904)   (669,242)
Reverse recapitalization with Cleantech Acquisition Corp, net (in Shares)             6,619,490      
Earnout shares placed in escrow         $ 750 (750)
Earnout shares placed in escrow (in Shares)             7,499,993      
Issuance of common stock for PIPE Investment         $ 310 30,999,690 31,000,000
Issuance of common stock for PIPE Investment (in Shares)             3,100,000      
Equity issuance costs         (12,582,000)   (12,582,000)
Balance at Sep. 30, 2022         $ 4,725 66,150,428 (59,881,986) 6,273,167
Balance (in Shares) at Sep. 30, 2022             47,250,771      
Net income (loss)         (8,223,116) (8,223,116)
Stock-based compensation         1,977,768 1,977,768
Balance at Dec. 31, 2022         $ 4,725 68,128,196 (68,105,102) 27,819
Balance (in Shares) at Dec. 31, 2022             47,250,771      
Net income (loss)         (10,180,020) (10,180,020)
Stock-based compensation         1,214,863 1,214,863
Exercise of stock options         $ 3 59,187 59,190
Exercise of stock options (in Shares)             30,504      
Balance at Mar. 31, 2023         $ 4,728 $ 69,402,246 $ (78,285,122) $ (8,878,148)
Balance (in Shares) at Mar. 31, 2023             47,281,275